Acinetobacter baumannii and Pseudomonas aeruginosa are gram-negative pathogens that
target immunocompromised patients. They express a variety of determinants that confer …

Abstract Objectives Multidrug-resistant (MDR) Acinetobacter baumannii is increasing in our
hospital and worldwide, raising the necessity of finding effective therapies. We aimed to …

Tigecycline has an extended spectrum of in vitro antimicrobial activities, including that
against multidrug-resistant Acinetobacter. After identifying bloodstream isolates of …

Acinetobacter baumannii is a pathogen of increasing concern, commonly causing outbreaks
in the hospital environment. Of particular concern, A. baumannii strains exhibiting resistance …

What is known and objective Acinetobacter baumannii is one of the most important
nosocomial pathogens with the ability to cause infections such as meningitis, pneumonia …

Acinetobacter baumannii is an important human pathogen responsible for a various type of
infections. These bacterial strains are generally resistant to numerous antibiotics. Therefore …

Acinetobacter baumannii is widely distributed in nature and in hospital settings and is a
common pathogen causing various infectious diseases. Currently, the drug resistance rate …

Objectives Tigecycline non-susceptibility in individual Acinetobacter baumannii isolates has
been associated with up-regulation of the resistance–nodulation–division (RND)-type efflux …

Objectives To investigate the mechanisms of tigecycline resistance in isogenic
Acinetobacter baumannii isolate pairs as well as 65 unique clinical A. baumannii isolates …

Background Infections sustained by multidrug-resistant (MDR) and pan-resistant
Acinetobacter baumannii have become a challenging problem in Intensive Care Units …